-
09:00-18:00 - Fund. António de Almeida
540 min
Emergencies in SAIDs
SpeakerÁlvaro Ferreira
SpeakerGraziela Carvalheiras
SpeakerIvo Santos Barreiro
SpeakerPedro Vita
SpeakerTomas Abrantes Da Fonseca
-
09:00-10:30 - Fund. António de Almeida
90 min
Theoretical Session “ From the organ to the Disease”- part I
- Hematologic Emergencies
- Neurological Emergencies
- Pulmonary Emergencies -
10:30-11:00 - Fund. António de Almeida
30 min
Coffee-break
-
11:00-12:30 - Fund. António de Almeida
90 min
Theoretical Session “ From the organ to the Disease”- part II
- Cardiac Emergencies
- Kidney Emergencies
- Therapeutic Techniques -
12:30-13:30 - Fund. António de Almeida
60 min
Lunch
-
13:30-14:15 - Fund. António de Almeida
45 min
Clinical Cases - Catastrophic Antiphospholipid Syndrome (cAPS)
-
14:15-15:00 - Fund. António de Almeida
45 min
Clinical Case – Lung – Kidney Syndrome
-
15:00-15:45 - Fund. António de Almeida
45 min
Clinical Case – Neuropsychiatric Lupus
-
15:45-16:30 - Fund. António de Almeida
45 min
Clinical Case – Antisynthetase Syndrome
-
16:30-17:00 - Fund. António de Almeida
30 min
Evaluation
-
17:00-17:30 - Fund. António de Almeida
30 min
Coffee-Break
-
17:30-18:00 - Fund. António de Almeida
30 min
Closing
Álvaro Ferreira
Consultor em Medicina Interna
Competência em doenças Autoimunes pela SPMI
Coordenador do Coorte de Espondilartrites da UIC
Unidade de Imunologia Clínica, ULSSA- Hospital Santo AntónioGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
Pedro Vita
Tomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
-
-
09:00-18:00 - Fund. António de Almeida
540 min
Emergencies in SAIDs
SpeakerÁlvaro Ferreira
SpeakerGraziela Carvalheiras
SpeakerIvo Santos Barreiro
SpeakerPedro Vita
SpeakerTomas Abrantes Da Fonseca
-
09:00-10:30 - Fund. António de Almeida
90 min
Theoretical Session “ From the organ to the Disease”- part I
- Hematologic Emergencies
- Neurological Emergencies
- Pulmonary Emergencies -
10:30-11:00 - Fund. António de Almeida
30 min
Coffee-break
-
11:00-12:30 - Fund. António de Almeida
90 min
Theoretical Session “ From the organ to the Disease”- part II
- Cardiac Emergencies
- Kidney Emergencies
- Therapeutic Techniques -
12:30-13:30 - Fund. António de Almeida
60 min
Lunch
-
13:30-14:15 - Fund. António de Almeida
45 min
Clinical Cases - Catastrophic Antiphospholipid Syndrome (cAPS)
-
14:15-15:00 - Fund. António de Almeida
45 min
Clinical Case – Lung – Kidney Syndrome
-
15:00-15:45 - Fund. António de Almeida
45 min
Clinical Case – Neuropsychiatric Lupus
-
15:45-16:30 - Fund. António de Almeida
45 min
Clinical Case – Antisynthetase Syndrome
-
16:30-17:00 - Fund. António de Almeida
30 min
Evaluation
-
17:00-17:30 - Fund. António de Almeida
30 min
Coffee-Break
-
17:30-18:00 - Fund. António de Almeida
30 min
Closing
Álvaro Ferreira
Consultor em Medicina Interna
Competência em doenças Autoimunes pela SPMI
Coordenador do Coorte de Espondilartrites da UIC
Unidade de Imunologia Clínica, ULSSA- Hospital Santo AntónioGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
Pedro Vita
Tomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
-
-
08:30-09:30
60 min
Poster tours and oral communications
Autoimmune Diseases (3); Systemic Erythematosus Lupus (1)
ChairMaria Teresa Faria De Mendonça
ChairCristina Rosario
PosterAnaïs Joachim
EP-01 - (163) - LATY136F MICE: A PRECLINICAL MODEL FOR IGG4-RD AND AUTOIMMUNE DISORDERSPosterAntónio Marinho
EP-02 - (164) - OCS USE IN PORTUGUESE SLE PATIENTS: PRELIMINARY RESULTS FROM TRANSFORM
PosterAndré Jesus
EP-04 - (170) - IGG4-RD AS A MALIGNANCY MIMICKER AND ITS DIAGNOSTIC CHALLENGE
PosterBeatriz Santos-Pereira
EP-05 - (171) - GLYCANS IN THE LOSS OF IMMUNOLOGICAL TOLERANCE THROUGH ΓΔT CELLS REGULATION
Maria Teresa Faria De Mendonça
Cristina Rosario
Anaïs Joachim
António Marinho
André Jesus
Beatriz Santos-Pereira
-
09:30-11:30 - Salão Nobre ICBAS
120 min
Behçet's Disease
ChairJoão Araújo Correia
ChairCarlos Jorge Magalhães Crespo
ChairAna Clara Coelho
SpeakerGülen Hatemi
Treat to Target on Behçet Disease
SpeakerAna Luísa Lopes Serpa Pinto
Review of vascular involvement in Behcet's disease
SpeakerMarta Costa Vaz De Matos
Review of the UIC case series
SpeakerInês Duro
Joint and Spondyloarthropathy in the UIC Behçet’s cohort
SpeakerIsabel Patrícia Fonseca Da Silva
Review of joint involvement and Spondyloarthropathy in Behcet's diseaseJoão Araújo Correia
João de Melo Sampaio de Araújo Correia, DN 16/11/59
· Licenciatura em Medicina pelo Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Portugal , a 28 de Julho de 1983.
· A 26 de Janeiro de 1993 titulação como Especialista de Medicina Interna.
· Desde 01-01-1995, é Assistente Hospitalar de Medicina Interna no Hospital Geral de Santo António, Centro Hospitalar do Porto, tendo desde 2016 o grau de Assistente Graduado Sénior.
· Docente desde 1995, na cadeira de Clínica Médica II (6º Ano Profissionalizante), atualmente como Professor Associado Convidado de Medicina do Mestrado Integrado Em Medicina do ICBAS/CHP.
· De Maio de 2000 até Maio de 2009, faz parte do Conselho Diretivo do Colégio de Especialidade de Medicina Interna, exercendo o cargo de Presidente nos últimos 3 anos.
· Faz parte da Unidade de Imunologia Clínica do HGSA, criada oficialmente em Maio de 2005, sendo responsável pelo Coorte de Doença de Behçet.
· Chefe de Equipa de Urgência desde Outubro de 2005 até á saída do SU a 31/12/2020.
· Diretor do Serviço de Medicina Interna do Centro Hospitalar do Porto desde 6/2009 a 7/2023.
· Secretário Geral do 17ºCongresso Nacional de Medicina Interna, Maio 2011.
· Presidente do 23º Congresso Nacional de Medicina Interna, Maio 2017.
· Honorary Fellow American College of Physicians , #03834251, Elected 4/2019.
· Presidente da Sociedade Portuguesa de Medicina Interna desde Junho de 2018 a Outubro de 2021.
· Sócio Honorário da Sociedade Portuguesa Medicina Interna, Outubro de 2021.
· Diretor Pedagógico e Científico e Diretor do Departamento de Ensino Pré-Graduado do Mestrado Integrado de Medicina do ICBAS / ULSSA-Porto, Maio/23.
Carlos Jorge Magalhães Crespo
· AH Graduado Sénior de Medicina Interna (aposentado do CHUC em Nov/21)
· Coordenador do Grupo que fez o 1º levantamento da causuística nacional sobre DB no NEDAI – Medicina Interna 1997. 4(4):225-232
· Membro do Council da International Society for BD
Ana Clara Coelho
Gülen Hatemi
Prof. Gülen Hatemi, MD, PhD
Gülen Hatemi is a Professor of Medicine in Istanbul University – Cerrahpasa, Department of Internal Medicine, Division of Rheumatology.
She is a member of the Behçet's Syndrome Research Center in Istanbul University-Cerrahpaşa, a multidisciplinary center specialized in research and care of patients with Behçet's syndrome. Her main research area is Behçet's syndrome and she has published several articles including drug trials and clinical research on this disorder. She has conducted a series of studies focused on understanding the life impact of Behçet’s syndrome.
She is also interested in outcome measures development. She is currently the convenor of the Disease Assessment Study Group of the International Society for Behçet’s Disease and is co-chairing the OMERACT Behçet’s Syndrome working group.
Ana Luísa Lopes Serpa Pinto
Marta Costa Vaz De Matos
Inês Duro
Isabel Patrícia Fonseca Da Silva
-
11:30-12:00 - Salão Nobre ICBAS
30 min
Coffee break
-
12:00-13:00 - Salão Nobre ICBAS
60 min
ANCA related Vasculitis
ChairMarta Isabel Rodrigues Casal Moura
ChairFernando Manuel Pavão Bandeira Lobão Salvador
ChairAndre Miguel Neto Real
SpeakerMarta Isabel Rodrigues Casal Moura
Treat to Target in AAV: Personalized Medicine and Advances in Complement TargetingSpeakerUlrich Specks
Treat to Target in AAV: Advancing the Efficacy and Safety of B-cell Depletion – How and Why?SpeakerMarta Isabel Rodrigues Casal Moura
Clinical Case in AAV: difficult to treat patients while excluding mimickersMarta Isabel Rodrigues Casal Moura
Fernando Manuel Pavão Bandeira Lobão Salvador
- Assistente Hospitalar Graduado de Medicina Interna na Unidade Local de Saúde de Trás-os-Montes e Alto Douro;
- Membro do Secretariado do Núcleo de Estudos de Doenças Autoimunes;
- Tesoureiro da Sociedade Portuguesa de Medicina Interna;
- Coordenador Norte do Colégio de Especialidade de Medicina Interna da Ordem dos Médicos;
- Presidente do Conselho Sub-Regional de Vila Real da Ordem dos Médicos;
- Revisor da Revista Medicina Interna, Clinical Rheumatology, BMJ Case Reports e membro do Conselho Editorial da European Journal of Internal Medicine;
- Docente na Escola Superior de Saúde da Universidade de Trás-os-Montes e Alto Douro.
Andre Miguel Neto Real
Assistente Hospitalar Graduado em Medicina Interna.
Assistente Hospitalar em Medicina Intensiva.
Coordenador da Unidade de Doenças Autoimunes da ULS Médio Tejo - Abrantes
Ulrich Specks
Ulrich Specks, M.D.
Dr. Specks received his medical and doctoral degree from the Rheinische Friedrich Wilhelms University, Bonn, Germany, completed Internal Medicine Residency and Pulmonary & Critical Care Medicine fellowship at Mayo Clinic Rochester, followed by a post-doctoral fellowship in Biochemistry at the Max-Planck-Institute in Martinsried near Munich, Germany. He’s been a faculty member at Mayo Clinic since 1992 and is Professor of Medicine at the Mayo Clinic College of Medicine & Science. Dr. Specks served as Education Chair and Program Director for the Pulmonary & Critical Care Medicine Fellowship 4/2003-12/2009 and Chair of the Division of Pulmonary & Critical Care Medicine 12/2012-1/2020.
Dr. Specks has had a career-long focus on ANCA-associated vasculitis through his clinical activities and widely published research. He’s made substantial contributions to the refinement of ANCA test methodologies and our understanding of optimal clinical applications of ANCA testing. Dr. Specks has introduced rituximab to the treatment of ANCA-associated vasculitis that lead to the label-enabling “Rituximab for ANCA-associated Vasculitis (RAVE)” trial, of which he was the co-Principal Investigator. He has also served as Mayo Clinic site-PI or on the steering committee of most randomized controlled trials in ANCA-associated vasculitis enrolling patients in the US. His current collaborative laboratory-based translational research focuses on pathogenic (vs non-pathogenic) interactions of PR3-ANCA with its antigen, PR3, and on the pathogenic role of PR3-specific B cells as potential targets for novel therapy approaches.
-
13:00-14:15 - Salão Nobre ICBAS
75 min
Lunch
-
14:15-14:30 - Salão Nobre ICBAS
15 min
Opening Session
SpeakerCarlos Vasconcelos
SpeakerAntónio Marinho
SpeakerAugusto Aguiar Branco
SpeakerAntónio Gonçalves
SpeakerHenrique Cyrne Carvalho
SpeakerJosé Torres Da Costa.
Carlos Vasconcelos
António Marinho
Augusto Aguiar Branco
António Gonçalves
Henrique Cyrne Carvalho
José Torres Da Costa.
-
14:30-15:00 - Salão Nobre ICBAS
30 min
T2T generic concept for SAIDs
ChairAntónio Marinho
SpeakerMarta Mosca
T2T generic concept for SAIDsAntónio Marinho
Marta Mosca
Dr. Mosca is Professor of Rheumatology at the University of Pisa and Head of the Rheumatology Unit at the Azienda Ospedaliera Universitaria Pisana, Italy. She is also head of the Fellowship Training Program in Rheumatology at the University of Pisa and member of the faculty of the Ph.D. Program in Genetics, Oncology and Clinical Medicine of the Consortium among the Universities of Pisa, Florence and Siena. She has participated to the development of European Alliance of Associations for Rheumatology (EULAR) recommendations in a number of different areas and she has coordinated the Development of recommendations for monitoring systemic lupus erythematosus (SLE) patients in clinical practice and in observational studies. She was also a member of the EULAR/American College of Rheumatology steering committee for the development of Classification Criteria for SLE and she is a member of the SLICC group. Dr. Mosca is a member of the scientific advisory board of LUPUS EUROPE, the European Association of SLE patients. Since December 2016, she has been the coordinator of the European Reference Network on “Rare and Hereditary Connective and Musculoskeletal Diseases” (RECONNET) supported by the European Commission.
Dr Mosca has served as Abstract Chair of the 2022 EULAR congress and Scientific Chair for the 2023 EULAR Congress. She has authored over 300 ISI publications on SLE and other connective tissue diseases. Her clinical activity covers systemic lupus erythematosus, pregnancy in RMDs, as well as other rare and complex connective tissue diseases and rheumatic diseases. -
15:00-16:30 - Salão Nobre ICBAS
90 min
IgG4-Related Disease
ChairTomas Abrantes Da Fonseca
ChairJorge Manuel Santos Fortuna
SpeakerEmanuel Della Torre
T2T in IgG4 Related DiseaseSpeakerTomas Abrantes Da Fonseca
Clinical CasesTomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
Jorge Manuel Santos Fortuna
Emanuel Della Torre
Dr Della Torre is an Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant Rheumatologist at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital (Milan, Italy). He received his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology at Vita-Salute San Raffaele (Milan, Italy) and trained as a Clinical-research Fellow and Post-doc at the Massachusetts General Hospital and Harvard Medical School (Boston, US). Dr. Della Torre established his own lab of Translational Immunology within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy). Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and with his seminal works characterized a novel autoimmune disease known as “IgG4-related disease”. Up to September 2025, his scientific publications received more than 8000 citations with an H-index of 42.
-
16:30-17:00 - Salão Nobre ICBAS
30 min
Coffee break
-
17:00-18:00 - Salão Nobre ICBAS
60 min
Antiphospholipid Syndrome
ChairGraziela Carvalheiras
ChairBruno Grima
SpeakerSavino Sciascia
T2T strategies in Antiphospholipid SyndromeSpeakerGraziela Carvalheiras
Clinical CasesGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Bruno Grima
Savino Sciascia
Professor Savino Sciascia is a Consultant at the Multidisciplinary Centre for Immunopathology and Rare Diseases, University di Torino, Italy.
His major research interests include the management of patients with autoimmune conditions, with a specific focus on Systemic Lupus Erythematosus, and antiphospholipid antibodies syndrome. He received his MD cum laude from the University of Turin Medical School. He earned his PhD in Complex Systems for Life Sciences investigating mathematic models for risk assessment in patients with autoimmune diseases in collaboration with the Lupus Unit, Guy's and St Thomas' Hospital, King’s College, London, UK.
-
09:30-11:30 - Salão Nobre ICBAS
120 min
Behçet's Disease
ChairJoão Araújo Correia
ChairCarlos Jorge Magalhães Crespo
ChairAna Clara Coelho
SpeakerGülen Hatemi
Treat to Target on Behçet Disease
SpeakerAna Luísa Lopes Serpa Pinto
Review of vascular involvement in Behcet's disease
SpeakerMarta Costa Vaz De Matos
Review of the UIC case series
SpeakerInês Duro
Joint and Spondyloarthropathy in the UIC Behçet’s cohort
SpeakerIsabel Patrícia Fonseca Da Silva
Review of joint involvement and Spondyloarthropathy in Behcet's diseaseJoão Araújo Correia
João de Melo Sampaio de Araújo Correia, DN 16/11/59
· Licenciatura em Medicina pelo Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Portugal , a 28 de Julho de 1983.
· A 26 de Janeiro de 1993 titulação como Especialista de Medicina Interna.
· Desde 01-01-1995, é Assistente Hospitalar de Medicina Interna no Hospital Geral de Santo António, Centro Hospitalar do Porto, tendo desde 2016 o grau de Assistente Graduado Sénior.
· Docente desde 1995, na cadeira de Clínica Médica II (6º Ano Profissionalizante), atualmente como Professor Associado Convidado de Medicina do Mestrado Integrado Em Medicina do ICBAS/CHP.
· De Maio de 2000 até Maio de 2009, faz parte do Conselho Diretivo do Colégio de Especialidade de Medicina Interna, exercendo o cargo de Presidente nos últimos 3 anos.
· Faz parte da Unidade de Imunologia Clínica do HGSA, criada oficialmente em Maio de 2005, sendo responsável pelo Coorte de Doença de Behçet.
· Chefe de Equipa de Urgência desde Outubro de 2005 até á saída do SU a 31/12/2020.
· Diretor do Serviço de Medicina Interna do Centro Hospitalar do Porto desde 6/2009 a 7/2023.
· Secretário Geral do 17ºCongresso Nacional de Medicina Interna, Maio 2011.
· Presidente do 23º Congresso Nacional de Medicina Interna, Maio 2017.
· Honorary Fellow American College of Physicians , #03834251, Elected 4/2019.
· Presidente da Sociedade Portuguesa de Medicina Interna desde Junho de 2018 a Outubro de 2021.
· Sócio Honorário da Sociedade Portuguesa Medicina Interna, Outubro de 2021.
· Diretor Pedagógico e Científico e Diretor do Departamento de Ensino Pré-Graduado do Mestrado Integrado de Medicina do ICBAS / ULSSA-Porto, Maio/23.
Carlos Jorge Magalhães Crespo
· AH Graduado Sénior de Medicina Interna (aposentado do CHUC em Nov/21)
· Coordenador do Grupo que fez o 1º levantamento da causuística nacional sobre DB no NEDAI – Medicina Interna 1997. 4(4):225-232
· Membro do Council da International Society for BD
Ana Clara Coelho
Gülen Hatemi
Prof. Gülen Hatemi, MD, PhD
Gülen Hatemi is a Professor of Medicine in Istanbul University – Cerrahpasa, Department of Internal Medicine, Division of Rheumatology.
She is a member of the Behçet's Syndrome Research Center in Istanbul University-Cerrahpaşa, a multidisciplinary center specialized in research and care of patients with Behçet's syndrome. Her main research area is Behçet's syndrome and she has published several articles including drug trials and clinical research on this disorder. She has conducted a series of studies focused on understanding the life impact of Behçet’s syndrome.
She is also interested in outcome measures development. She is currently the convenor of the Disease Assessment Study Group of the International Society for Behçet’s Disease and is co-chairing the OMERACT Behçet’s Syndrome working group.
Ana Luísa Lopes Serpa Pinto
Marta Costa Vaz De Matos
Inês Duro
Isabel Patrícia Fonseca Da Silva
-
11:30-12:00 - Salão Nobre ICBAS
30 min
Coffee break
-
12:00-13:00 - Salão Nobre ICBAS
60 min
ANCA related Vasculitis
ChairMarta Isabel Rodrigues Casal Moura
ChairFernando Manuel Pavão Bandeira Lobão Salvador
ChairAndre Miguel Neto Real
SpeakerMarta Isabel Rodrigues Casal Moura
Treat to Target in AAV: Personalized Medicine and Advances in Complement TargetingSpeakerUlrich Specks
Treat to Target in AAV: Advancing the Efficacy and Safety of B-cell Depletion – How and Why?SpeakerMarta Isabel Rodrigues Casal Moura
Clinical Case in AAV: difficult to treat patients while excluding mimickersMarta Isabel Rodrigues Casal Moura
Fernando Manuel Pavão Bandeira Lobão Salvador
- Assistente Hospitalar Graduado de Medicina Interna na Unidade Local de Saúde de Trás-os-Montes e Alto Douro;
- Membro do Secretariado do Núcleo de Estudos de Doenças Autoimunes;
- Tesoureiro da Sociedade Portuguesa de Medicina Interna;
- Coordenador Norte do Colégio de Especialidade de Medicina Interna da Ordem dos Médicos;
- Presidente do Conselho Sub-Regional de Vila Real da Ordem dos Médicos;
- Revisor da Revista Medicina Interna, Clinical Rheumatology, BMJ Case Reports e membro do Conselho Editorial da European Journal of Internal Medicine;
- Docente na Escola Superior de Saúde da Universidade de Trás-os-Montes e Alto Douro.
Andre Miguel Neto Real
Assistente Hospitalar Graduado em Medicina Interna.
Assistente Hospitalar em Medicina Intensiva.
Coordenador da Unidade de Doenças Autoimunes da ULS Médio Tejo - Abrantes
Ulrich Specks
Ulrich Specks, M.D.
Dr. Specks received his medical and doctoral degree from the Rheinische Friedrich Wilhelms University, Bonn, Germany, completed Internal Medicine Residency and Pulmonary & Critical Care Medicine fellowship at Mayo Clinic Rochester, followed by a post-doctoral fellowship in Biochemistry at the Max-Planck-Institute in Martinsried near Munich, Germany. He’s been a faculty member at Mayo Clinic since 1992 and is Professor of Medicine at the Mayo Clinic College of Medicine & Science. Dr. Specks served as Education Chair and Program Director for the Pulmonary & Critical Care Medicine Fellowship 4/2003-12/2009 and Chair of the Division of Pulmonary & Critical Care Medicine 12/2012-1/2020.
Dr. Specks has had a career-long focus on ANCA-associated vasculitis through his clinical activities and widely published research. He’s made substantial contributions to the refinement of ANCA test methodologies and our understanding of optimal clinical applications of ANCA testing. Dr. Specks has introduced rituximab to the treatment of ANCA-associated vasculitis that lead to the label-enabling “Rituximab for ANCA-associated Vasculitis (RAVE)” trial, of which he was the co-Principal Investigator. He has also served as Mayo Clinic site-PI or on the steering committee of most randomized controlled trials in ANCA-associated vasculitis enrolling patients in the US. His current collaborative laboratory-based translational research focuses on pathogenic (vs non-pathogenic) interactions of PR3-ANCA with its antigen, PR3, and on the pathogenic role of PR3-specific B cells as potential targets for novel therapy approaches.
-
13:00-14:15 - Salão Nobre ICBAS
75 min
Lunch
-
14:15-14:30 - Salão Nobre ICBAS
15 min
Opening Session
SpeakerCarlos Vasconcelos
SpeakerAntónio Marinho
SpeakerAugusto Aguiar Branco
SpeakerAntónio Gonçalves
SpeakerHenrique Cyrne Carvalho
SpeakerJosé Torres Da Costa.
Carlos Vasconcelos
António Marinho
Augusto Aguiar Branco
António Gonçalves
Henrique Cyrne Carvalho
José Torres Da Costa.
-
14:30-15:00 - Salão Nobre ICBAS
30 min
T2T generic concept for SAIDs
ChairAntónio Marinho
SpeakerMarta Mosca
T2T generic concept for SAIDsAntónio Marinho
Marta Mosca
Dr. Mosca is Professor of Rheumatology at the University of Pisa and Head of the Rheumatology Unit at the Azienda Ospedaliera Universitaria Pisana, Italy. She is also head of the Fellowship Training Program in Rheumatology at the University of Pisa and member of the faculty of the Ph.D. Program in Genetics, Oncology and Clinical Medicine of the Consortium among the Universities of Pisa, Florence and Siena. She has participated to the development of European Alliance of Associations for Rheumatology (EULAR) recommendations in a number of different areas and she has coordinated the Development of recommendations for monitoring systemic lupus erythematosus (SLE) patients in clinical practice and in observational studies. She was also a member of the EULAR/American College of Rheumatology steering committee for the development of Classification Criteria for SLE and she is a member of the SLICC group. Dr. Mosca is a member of the scientific advisory board of LUPUS EUROPE, the European Association of SLE patients. Since December 2016, she has been the coordinator of the European Reference Network on “Rare and Hereditary Connective and Musculoskeletal Diseases” (RECONNET) supported by the European Commission.
Dr Mosca has served as Abstract Chair of the 2022 EULAR congress and Scientific Chair for the 2023 EULAR Congress. She has authored over 300 ISI publications on SLE and other connective tissue diseases. Her clinical activity covers systemic lupus erythematosus, pregnancy in RMDs, as well as other rare and complex connective tissue diseases and rheumatic diseases. -
15:00-16:30 - Salão Nobre ICBAS
90 min
IgG4-Related Disease
ChairTomas Abrantes Da Fonseca
ChairJorge Manuel Santos Fortuna
SpeakerEmanuel Della Torre
T2T in IgG4 Related DiseaseSpeakerTomas Abrantes Da Fonseca
Clinical CasesTomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
Jorge Manuel Santos Fortuna
Emanuel Della Torre
Dr Della Torre is an Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant Rheumatologist at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital (Milan, Italy). He received his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology at Vita-Salute San Raffaele (Milan, Italy) and trained as a Clinical-research Fellow and Post-doc at the Massachusetts General Hospital and Harvard Medical School (Boston, US). Dr. Della Torre established his own lab of Translational Immunology within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy). Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and with his seminal works characterized a novel autoimmune disease known as “IgG4-related disease”. Up to September 2025, his scientific publications received more than 8000 citations with an H-index of 42.
-
16:30-17:00 - Salão Nobre ICBAS
30 min
Coffee break
-
17:00-18:00 - Salão Nobre ICBAS
60 min
Antiphospholipid Syndrome
ChairGraziela Carvalheiras
ChairBruno Grima
SpeakerSavino Sciascia
T2T strategies in Antiphospholipid SyndromeSpeakerGraziela Carvalheiras
Clinical CasesGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Bruno Grima
Savino Sciascia
Professor Savino Sciascia is a Consultant at the Multidisciplinary Centre for Immunopathology and Rare Diseases, University di Torino, Italy.
His major research interests include the management of patients with autoimmune conditions, with a specific focus on Systemic Lupus Erythematosus, and antiphospholipid antibodies syndrome. He received his MD cum laude from the University of Turin Medical School. He earned his PhD in Complex Systems for Life Sciences investigating mathematic models for risk assessment in patients with autoimmune diseases in collaboration with the Lupus Unit, Guy's and St Thomas' Hospital, King’s College, London, UK.
-
08:00-09:00
60 min
Poster tours and oral communications
Autoimmune Diseases (4); Autoinflammatory Diseases (1)
ChairMaria De Fátima Graça Farinha
ChairElisabete Da Conceição Lourenço Pinelo
PosterA.Beatriz Ferreira
EP-06 - (169) - PARADOXICAL PSORIASIS WITH ANTI-TNF: INSIGHTS FROM A CLINICAL COHORT
PosterFrancisca De Sousa Magalhaes
EP-07 - (168) - ACUTE NEUROLOGICAL MANIFESTATIONS IN CATASTROPHIC ANTIPHOSPHOLIPIDID SYNDROME
PosterA. Beatriz Ferreira
EP-08 - (172) - NLRP12-RELATED AUTOINFLAMMATORY SYNDROME WITH MARKED IL-1 BLOCKADE RESPONSE
PosterMaria Lages
EP-09 - (167) - INTERPRETING DISCORDANT ANTINUCLEAR ANTIBODIES (ANA) AND ANTI-SCL-70 RESULTS
PosterMiguel Gouveia
EP - (165) - UNUSUAL ANA PATTERN WITH HOMOGENEOUS-LIKE METAPHASE POSITIVITY IN PSORIASIS
Maria De Fátima Graça Farinha
Elisabete Da Conceição Lourenço Pinelo
A.Beatriz Ferreira
Francisca De Sousa Magalhaes
A. Beatriz Ferreira
Maria Lages
Miguel Gouveia
-
09:00-10:30 - Salão Nobre ICBAS
90 min
Myositis
ChairMarta Sofia Carapeto Amaral
ChairCarlos Filipe Gonçalves Lage Carneiro
ChairEdite Manuel Peixoto Pereira Braz
SpeakerAna Campar
Severity definition in Disease Modification Concept
SpeakerJoana Rita De Matos Caetano
Strategies to achieve remission or low disease activitySpeakerAna Campar
Clinical Cases
SpeakerJoana Rita De Matos Caetano
Clinical CasesMarta Sofia Carapeto Amaral
Consultant in Internal Medicine, with special dedication to immune-mediated diseases, at UDIMS, Hospital Fernando Fonseca, ULS Amadora-Sintra
PhD in Medicine by NOVA Medical School
Lecturer and Researcher in NOVA Medical School
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
Edite Manuel Peixoto Pereira Braz
Ana Campar
Joana Rita De Matos Caetano
-
10:30-11:00 - Salão Nobre ICBAS
30 min
Coffee break
-
11:00-11:30 - Salão Nobre ICBAS
30 min
Panel on One Health and Autoimmune Diseases
SpeakerLuís Manuel Barreto Campos
SpeakerAntónio Marinho
SpeakerCarlos Vasconcelos
Luís Manuel Barreto Campos
Luís Campos é médico internista, fundador e presidente do Conselho Português para a Saúde e Ambiente, comissário do Plano Nacional de Saúde 2021-2030 e presidente do Comité de Qualidade de Cuidados e Assuntos Profissionais da Federação Europeia de Medicina Interna. Entre outras funções anteriores, foi coordenador para os cuidados hospitalares do Grupo de Apoio à Implementação de Políticas de Saúde do Ministério da Saúde, diretor dos Serviços de Medicina Interna e de Urgência do Hospital São Francisco Xavier, professor da NOVA Medical School, presidente da Sociedade Portuguesa de Medicina Interna (SPMI), presidente do Conselho Nacional para a Qualidade em Saúde, coordenador nacional do Registo de Saúde Eletrónico, coordenador nacional do Grupo de Estudos de Autoimunidade da SPMI e conselheiro dos Governos Regionais de Macau e Açores. Luis Campos apresentou mais de 600 conferências, foi autor ou coautor de cerca de 340 comunicações, dezenas de publicações e 16 capítulos de livros. Foi coeditor de dois livros. É Honorary Fellow do American College of Physicians e Fellow da European Federation of Internal Medicine. Recebeu o Prémio Nacional de Medicina Interna em 2024.
António Marinho
Carlos Vasconcelos
-
11:30-13:00 - Salão Nobre ICBAS
90 min
Large Vessel Vasculitis
ChairManuel Nuno Vital Mendes Riso
ChairNatália Oliveira
ChairSandra Mafalda Marques Santos
SpeakerMilena Bond
T2T in Large Vessel VasculitisSpeakerTomas Abrantes Da Fonseca
Novalties in clinical and imagiological Large Vessel VasculitisManuel Nuno Vital Mendes Riso
SÚMULA CURRICULAR
Nuno Riso, Chefe de Serviço de Medicina Interna
Desenvolveu a sua principal atividade profissional durante 40 anos nos Hospitais Civis de Lisboa atualmente designados como Unidade Local de Saúde S. José, maioritariamente no Hospital de Curry Cabral passando por todos os graus da carreira hospitalar, tendo ultimamente exercido o cargo de Diretor do Serviço7.2. de Medicina Interna. Aposentado da função pública em agosto de 2015.
Exerce clínica em consultório privado em Lisboa desde 1986.
Membro fundador do Núcleo de Estudos de Doenças Auto-Imunes da Sociedade Portuguesa de Medicina Interna, tendo sido seu responsável durante 10 anos e responsável da Unidade de Doenças Auto-Imunes do Hospital de Curry Cabral.
Foi Diretor do Internato Médico dos Hospitais Civis de Lisboa e do Hospital de Curry Cabral, e Presidente da Comissão Regional do Internato Médico da Zona Sul.
Foi ainda Prof. Auxiliar Convidado da Nova Medical School- Faculdade de Ciências Médicas da Universidade Nova de Lisboa.
Realizou o Curso de Formação em Codificação Clínica da Escola Nacional de Saúde Pública
Realizou uma Pós-Graduação em Gestão de Unidades de Saúde da Universidade Católica Portuguesa.
Realizou o Curso de Medicina do Trabalho da Escola Nacional de Saúde Publica.
Natália Oliveira
Assistente Hospitalar Graduada em Medicina Interna.
Coordenadora da Unidade de Doenças Autoimunes da ULS Tâmega e Sousa (Penafiel).
Sandra Mafalda Marques Santos
AGS de Medicina Interna na ULS EDV
Certificação em Doenças Autoimunes pelo NEDAI, SPMI
Conselho Editorial da RPMI e SPMI Case Reports
Membro dos Corpos Sociais da SPMI
https://orcid.org/0000-0001-8432-1968
Milena Bond
Dr. Milena Bond is a consultant rheumatologist at the Department of Rheumatology of the South Tyrol Health Trust, Italy, and a PhD student at Paracelsus Medical University in Salzburg, Austria. She is actively involved in several international collaborations on systemic vasculitis and polymyalgia rheumatica, including ACR and EULAR task forces, and has authored several publications in the field of vasculitis. Dr. Bond is also an active member of EMEUNET (Emerging EULAR Network), where she serves on the Sub-Committee for Visibility and Global Affairs."
Tomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
-
13:00-14:00 - Salão Nobre ICBAS
60 min
Lunch
-
14:00-15:45 - Salão Nobre ICBAS
105 min
Systemic Sclerosis
ChairÁlvaro Ferreira
ChairLèlita Santos
ChairCristiana Alexandra Rodrigues Almeida
SpeakerSusana Oliveira
Strategies to achieve remission or low disease activitySpeakerJosé António Pereira Delgado Alves
New pharmacological pathways to achieve remission
SpeakerIsabel Almeida
Clinical CasesÁlvaro Ferreira
Consultor em Medicina Interna
Competência em doenças Autoimunes pela SPMI
Coordenador do Coorte de Espondilartrites da UIC
Unidade de Imunologia Clínica, ULSSA- Hospital Santo AntónioLèlita Santos
PhD in Internal Medicine from the Faculty of Medicine of the University of Coimbra, Portugal
Senior Graduate Hospital Assistant in Internal Medicine at ULS Coimbra
Head of the Microcirculation Laboratory of the Internal Medicine Department at ULS Coimbra.
Coordinator of the Outpatient Clinic for Systemic Autoimmune Diseases of the Internal Medicine Department at ULS Coimbra
LÈLITA SANTOS, MD, PhD, FACP (hon.), FEFIM
Cristiana Alexandra Rodrigues Almeida
Susana Oliveira
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 120 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
Isabel Almeida
-
15:45-16:15 - Salão Nobre ICBAS
30 min
The Future of Autoimmunity
ChairCarlos Dias
SpeakerYehuda Shoenfeld
The Future of Autoimmunity
Carlos Dias
Yehuda Shoenfeld
#We are delaing with Posr Covid as an autoimmune diseases ( mechanisms)\
#Anti GPCR autoantibodies and autonomic nervous system involvement
#Fibromyalgia as an autoimmune diseases
#ASIA syndrome also in cosmetic hyaline injections
# Why we develop autoimmune disease -
16:15-16:45 - Salão Nobre ICBAS
30 min
Coffee break
-
16:45-18:00 - Salão Nobre ICBAS
75 min
Sjögren’s Disease
ChairIvone Emília Melo Valadão
ChairGlória Alves
SpeakerGaëtane Nocturne
Strategies and new pharmacological pathways to achieve remission or low disease activitySpeakerFrederico Rafael Luís Batista
Severity definition and stratification in Sjögren’s DiseaseSpeakerIvone Emília Melo Valadão
Clinical CasesSpeakerIvo Santos Barreiro
Clinical CasesIvone Emília Melo Valadão
Glória Alves
Gaëtane Nocturne
Rheumatologist and immunologist. I am professor in the rheumatology department of Paris-Saclay University led by Pr Xavier Mariette. I conduct basic and translational research dedicated to pathogenesis of pSS, role of B cells in autoimmune diseases and the transition between autoimmunity and lymphoma.
My Research topics:
• Sjogren’s syndrome
• Lymphomagenesis associated with autoimmunity
• B cell auto-immunity
• Safety of immunosuppressive drugs
My Fields of clinical expertise:
• Connective tissue disease and especially Sjogren’s syndrome (centre maladie rare)
• Lymphomas complicating autoimmunity
• Inflammatory rheumatisms (Rheumatoid arthritis, Spondyloarthritis)Frederico Rafael Luís Batista
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
-
09:00-10:30 - Salão Nobre ICBAS
90 min
Myositis
ChairMarta Sofia Carapeto Amaral
ChairCarlos Filipe Gonçalves Lage Carneiro
ChairEdite Manuel Peixoto Pereira Braz
SpeakerAna Campar
Severity definition in Disease Modification Concept
SpeakerJoana Rita De Matos Caetano
Strategies to achieve remission or low disease activitySpeakerAna Campar
Clinical Cases
SpeakerJoana Rita De Matos Caetano
Clinical CasesMarta Sofia Carapeto Amaral
Consultant in Internal Medicine, with special dedication to immune-mediated diseases, at UDIMS, Hospital Fernando Fonseca, ULS Amadora-Sintra
PhD in Medicine by NOVA Medical School
Lecturer and Researcher in NOVA Medical School
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
Edite Manuel Peixoto Pereira Braz
Ana Campar
Joana Rita De Matos Caetano
-
10:30-11:00 - Salão Nobre ICBAS
30 min
Coffee break
-
11:00-11:30 - Salão Nobre ICBAS
30 min
Panel on One Health and Autoimmune Diseases
SpeakerLuís Manuel Barreto Campos
SpeakerAntónio Marinho
SpeakerCarlos Vasconcelos
Luís Manuel Barreto Campos
Luís Campos é médico internista, fundador e presidente do Conselho Português para a Saúde e Ambiente, comissário do Plano Nacional de Saúde 2021-2030 e presidente do Comité de Qualidade de Cuidados e Assuntos Profissionais da Federação Europeia de Medicina Interna. Entre outras funções anteriores, foi coordenador para os cuidados hospitalares do Grupo de Apoio à Implementação de Políticas de Saúde do Ministério da Saúde, diretor dos Serviços de Medicina Interna e de Urgência do Hospital São Francisco Xavier, professor da NOVA Medical School, presidente da Sociedade Portuguesa de Medicina Interna (SPMI), presidente do Conselho Nacional para a Qualidade em Saúde, coordenador nacional do Registo de Saúde Eletrónico, coordenador nacional do Grupo de Estudos de Autoimunidade da SPMI e conselheiro dos Governos Regionais de Macau e Açores. Luis Campos apresentou mais de 600 conferências, foi autor ou coautor de cerca de 340 comunicações, dezenas de publicações e 16 capítulos de livros. Foi coeditor de dois livros. É Honorary Fellow do American College of Physicians e Fellow da European Federation of Internal Medicine. Recebeu o Prémio Nacional de Medicina Interna em 2024.
António Marinho
Carlos Vasconcelos
-
11:30-13:00 - Salão Nobre ICBAS
90 min
Large Vessel Vasculitis
ChairManuel Nuno Vital Mendes Riso
ChairNatália Oliveira
ChairSandra Mafalda Marques Santos
SpeakerMilena Bond
T2T in Large Vessel VasculitisSpeakerTomas Abrantes Da Fonseca
Novalties in clinical and imagiological Large Vessel VasculitisManuel Nuno Vital Mendes Riso
SÚMULA CURRICULAR
Nuno Riso, Chefe de Serviço de Medicina Interna
Desenvolveu a sua principal atividade profissional durante 40 anos nos Hospitais Civis de Lisboa atualmente designados como Unidade Local de Saúde S. José, maioritariamente no Hospital de Curry Cabral passando por todos os graus da carreira hospitalar, tendo ultimamente exercido o cargo de Diretor do Serviço7.2. de Medicina Interna. Aposentado da função pública em agosto de 2015.
Exerce clínica em consultório privado em Lisboa desde 1986.
Membro fundador do Núcleo de Estudos de Doenças Auto-Imunes da Sociedade Portuguesa de Medicina Interna, tendo sido seu responsável durante 10 anos e responsável da Unidade de Doenças Auto-Imunes do Hospital de Curry Cabral.
Foi Diretor do Internato Médico dos Hospitais Civis de Lisboa e do Hospital de Curry Cabral, e Presidente da Comissão Regional do Internato Médico da Zona Sul.
Foi ainda Prof. Auxiliar Convidado da Nova Medical School- Faculdade de Ciências Médicas da Universidade Nova de Lisboa.
Realizou o Curso de Formação em Codificação Clínica da Escola Nacional de Saúde Pública
Realizou uma Pós-Graduação em Gestão de Unidades de Saúde da Universidade Católica Portuguesa.
Realizou o Curso de Medicina do Trabalho da Escola Nacional de Saúde Publica.
Natália Oliveira
Assistente Hospitalar Graduada em Medicina Interna.
Coordenadora da Unidade de Doenças Autoimunes da ULS Tâmega e Sousa (Penafiel).
Sandra Mafalda Marques Santos
AGS de Medicina Interna na ULS EDV
Certificação em Doenças Autoimunes pelo NEDAI, SPMI
Conselho Editorial da RPMI e SPMI Case Reports
Membro dos Corpos Sociais da SPMI
https://orcid.org/0000-0001-8432-1968
Milena Bond
Dr. Milena Bond is a consultant rheumatologist at the Department of Rheumatology of the South Tyrol Health Trust, Italy, and a PhD student at Paracelsus Medical University in Salzburg, Austria. She is actively involved in several international collaborations on systemic vasculitis and polymyalgia rheumatica, including ACR and EULAR task forces, and has authored several publications in the field of vasculitis. Dr. Bond is also an active member of EMEUNET (Emerging EULAR Network), where she serves on the Sub-Committee for Visibility and Global Affairs."
Tomas Abrantes Da Fonseca
• 2006 - 2012 Master Degree in Medicine, Instituto Ciências Biomédicas Abel Salazar, Porto;
• 01-12/2013 - General Internship, Hospital Padre Américo, Centro Hospitalar entre Tâmega e Sousa;
• 2014 - 2018 Specialization in Internal Medicine, Unidade Local de Saúde de Santo António (ULSSA)
• 2019 - October 2022 Internal Medicine assistant on Internal Medicine in the medical ward, Hospital Santo António, ULSSA;
• 2019 - today (since October 2022 on full time) Medical assistant of Unidade Imunologia Clinica, ULSSA;
• 2015 - 2016 – Invited assistant on the practical classes of Infectious diseases (5th year of Master Degree in Medicine);
• 2016 - today Invited assistant on the practical classes of Clinical Immunology (5th year of Master Degree in Medicine);
• 2020 - 2021 Coordination and Chief of Staff in Units dedicated to COVID-19 (general ward), ULSSA;
• 2021- today Medical coordinator of urgency and emergency department (Monday shift), ULSSA;
• 2021-today Co-coordinator of multidisciplinary team of toxicities related to cancer immunotherapy (Consulta Multidisciplinar de ToxicidadesnImunomediadas), ULSSA;
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of IgG4-RD cohort (ERN ReCONNET);
• 2022-today Local coordinator (Unidade Imunologia Clínica, ULSSA) of systemic vasculitis cohort (ERN RITA);
• 2022-today Coordinator and main interlocutor of inward autoimmune patients, ULSSA;
• 2022-today Coordinator of internship (Internal Medicine Residency) of Clinical Immunology on Unidade Imunologia Clinica, ULSSA
• 2023-today Coordinator of multidisciplinary team of Fragility Fratures (Grupo Osteoporose Fraturária), ULSSA;
-
13:00-14:00 - Salão Nobre ICBAS
60 min
Lunch
-
14:00-15:45 - Salão Nobre ICBAS
105 min
Systemic Sclerosis
ChairÁlvaro Ferreira
ChairLèlita Santos
ChairCristiana Alexandra Rodrigues Almeida
SpeakerSusana Oliveira
Strategies to achieve remission or low disease activitySpeakerJosé António Pereira Delgado Alves
New pharmacological pathways to achieve remission
SpeakerIsabel Almeida
Clinical CasesÁlvaro Ferreira
Consultor em Medicina Interna
Competência em doenças Autoimunes pela SPMI
Coordenador do Coorte de Espondilartrites da UIC
Unidade de Imunologia Clínica, ULSSA- Hospital Santo AntónioLèlita Santos
PhD in Internal Medicine from the Faculty of Medicine of the University of Coimbra, Portugal
Senior Graduate Hospital Assistant in Internal Medicine at ULS Coimbra
Head of the Microcirculation Laboratory of the Internal Medicine Department at ULS Coimbra.
Coordinator of the Outpatient Clinic for Systemic Autoimmune Diseases of the Internal Medicine Department at ULS Coimbra
LÈLITA SANTOS, MD, PhD, FACP (hon.), FEFIM
Cristiana Alexandra Rodrigues Almeida
Susana Oliveira
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 120 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
Isabel Almeida
-
15:45-16:15 - Salão Nobre ICBAS
30 min
The Future of Autoimmunity
ChairCarlos Dias
SpeakerYehuda Shoenfeld
The Future of Autoimmunity
Carlos Dias
Yehuda Shoenfeld
#We are delaing with Posr Covid as an autoimmune diseases ( mechanisms)\
#Anti GPCR autoantibodies and autonomic nervous system involvement
#Fibromyalgia as an autoimmune diseases
#ASIA syndrome also in cosmetic hyaline injections
# Why we develop autoimmune disease -
16:15-16:45 - Salão Nobre ICBAS
30 min
Coffee break
-
16:45-18:00 - Salão Nobre ICBAS
75 min
Sjögren’s Disease
ChairIvone Emília Melo Valadão
ChairGlória Alves
SpeakerGaëtane Nocturne
Strategies and new pharmacological pathways to achieve remission or low disease activitySpeakerFrederico Rafael Luís Batista
Severity definition and stratification in Sjögren’s DiseaseSpeakerIvone Emília Melo Valadão
Clinical CasesSpeakerIvo Santos Barreiro
Clinical CasesIvone Emília Melo Valadão
Glória Alves
Gaëtane Nocturne
Rheumatologist and immunologist. I am professor in the rheumatology department of Paris-Saclay University led by Pr Xavier Mariette. I conduct basic and translational research dedicated to pathogenesis of pSS, role of B cells in autoimmune diseases and the transition between autoimmunity and lymphoma.
My Research topics:
• Sjogren’s syndrome
• Lymphomagenesis associated with autoimmunity
• B cell auto-immunity
• Safety of immunosuppressive drugs
My Fields of clinical expertise:
• Connective tissue disease and especially Sjogren’s syndrome (centre maladie rare)
• Lymphomas complicating autoimmunity
• Inflammatory rheumatisms (Rheumatoid arthritis, Spondyloarthritis)Frederico Rafael Luís Batista
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
-
09:30-11:30 - Salão Nobre ICBAS
120 min
Systemic Lupus Erythematosus
ChairRaquel Faria
ChairAntónio Luís Dos Santos Lamas
ChairJosé António Pereira Delgado Alves
ChairLuís Inês
SpeakerArnaud Laurent
Severity definition in Disease Modification ConceptSpeakerCarlos Vasconcelos
Strategies to achieve remission or low disease activitySpeakerAntónio Marinho
Strategies to achieve remission or low disease activitySpeakerMariele Gatto
New pharmacological pathways to achieve remissionRaquel Faria
António Luís Dos Santos Lamas
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 120 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
Luís Inês
Arnaud Laurent
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
X acccount: @LupusreferenceLaurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on patient-centered care of those living with Systemic Lupus Erythematosus (SLE). He is leading an international research network focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published >300 articles in the field of rare diseases and is currently leading several international taskforces and actions for SLE. Professor Arnaud is the Past-President of the European Lupus Society (SLEuro) and is Elected Member of the Strategic board of the European Reference Network for rare diseases ReCONNET. He is also the curator of an X account (@Lupusreference) about lupus education, followed by >19k people.
Carlos Vasconcelos
António Marinho
Mariele Gatto
Current position
Since 1/04/2023
Associate Professor for Rheumatology
Unit of Rheumatology
Dept of Clinical & Biological Sciences
University of Turin
Short personal summary
I am a rheumatologist and clinical scientist deeply committed to patient care and translational research with a dedicated focus on SLE and lupus nephritis.
In the clinic, I lead the outpatient clinic for SLE patients and systemic connective tissue diseases, providing a renovated approach to their treatment strategies which refers to the latest treat-to-target perspective and optimized drug combination. Besides, I hold continuous multidisciplinary interactions with colleagues from other fields e.g. nephrologists and pulmonologists aimed at harmonizing the approach to our patients and at integrating the latest advancements in rheumatology to deliver the best possible care.
Driven by the desire to join clinical and lab research, my academic background includes a Ph.D. and post-doctoral experience conducted in specialized centers abroad (Charité hospital Berlin and Gothenburg University in Sweden) where I focused on the study of B cell abnormalities in SLE, LN as well as other autoimmune conditions, gaining skills in laboratory research including flow-cytometry, cell culturing and stimulation and RNA extraction, and parallelly developing mentoring skills for younger fellows.
I recognize the importance of collaboration in the scientific community and am fortunate to maintain connections with colleagues around the world, which leads to a continuous enrichment in knowledge and to fruitful cooperations resulting in joint research projects and exchange of younger fellows/students between our academic centers.
In essence, my journey in patient care and research always brought me at the intersection of clinical practice and scientific exploration, constantly learning and humbly contributing to original advancements in the field of SLE and LN.
My ultimate goal is to make a positive impact on the lives of individuals dealing with lupus and connective tissue diseases, and to extend my fondness to younger fellows.
-
11:30-12:00 - Salão Nobre ICBAS
30 min
Coffee break
-
12:00-12:45 - Salão Nobre ICBAS
45 min
Highligts: summary and future agenda
SpeakerLuísa Viveiros
SpeakerAna Marçal
SpeakerJoão Guilherme Neves Maia
SpeakerMarta Cunha
Luísa Viveiros
Ana Marçal
João Guilherme Neves Maia
Marta Cunha
-
12:45-13:00 - Salão Nobre ICBAS
15 min
Closing Session
-
14:45-16:45 - Salão Nobre ICBAS
120 min
Autoimmune Disease Patient Meeting
SpeakerCarlos Vasconcelos
New Treatment Strategies: What They Mean in Clinical PracticeSpeakerAntónio Marinho
New Drugs in Autoimmune DiseasesSpeakerDaniel Guimarães De Oliveira
How Patients Can Influence Autoimmune Disease Consultations from the Physician’s PerspectiveCarlos Vasconcelos
António Marinho
Daniel Guimarães De Oliveira
Dr. Daniel Guimarães de Oliveira is an Internist dedicated to immune-mediated diseases. He works at the Autoimmune Diseases and Immunology Unit (UDAI) of ULS Tâmega e Sousa as well as in private practice. His clinical and research interests focus on systemic lupus erythematosus (SLE). He leads national and international projects on social determinants of health, quality of life, and the gut microbiome in lupus, and is actively engaged in patient involvement and co-design initiatives.
-
09:30-11:30 - Salão Nobre ICBAS
120 min
Systemic Lupus Erythematosus
ChairRaquel Faria
ChairAntónio Luís Dos Santos Lamas
ChairJosé António Pereira Delgado Alves
ChairLuís Inês
SpeakerArnaud Laurent
Severity definition in Disease Modification ConceptSpeakerCarlos Vasconcelos
Strategies to achieve remission or low disease activitySpeakerAntónio Marinho
Strategies to achieve remission or low disease activitySpeakerMariele Gatto
New pharmacological pathways to achieve remissionRaquel Faria
António Luís Dos Santos Lamas
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 120 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
Luís Inês
Arnaud Laurent
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
X acccount: @LupusreferenceLaurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on patient-centered care of those living with Systemic Lupus Erythematosus (SLE). He is leading an international research network focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published >300 articles in the field of rare diseases and is currently leading several international taskforces and actions for SLE. Professor Arnaud is the Past-President of the European Lupus Society (SLEuro) and is Elected Member of the Strategic board of the European Reference Network for rare diseases ReCONNET. He is also the curator of an X account (@Lupusreference) about lupus education, followed by >19k people.
Carlos Vasconcelos
António Marinho
Mariele Gatto
Current position
Since 1/04/2023
Associate Professor for Rheumatology
Unit of Rheumatology
Dept of Clinical & Biological Sciences
University of Turin
Short personal summary
I am a rheumatologist and clinical scientist deeply committed to patient care and translational research with a dedicated focus on SLE and lupus nephritis.
In the clinic, I lead the outpatient clinic for SLE patients and systemic connective tissue diseases, providing a renovated approach to their treatment strategies which refers to the latest treat-to-target perspective and optimized drug combination. Besides, I hold continuous multidisciplinary interactions with colleagues from other fields e.g. nephrologists and pulmonologists aimed at harmonizing the approach to our patients and at integrating the latest advancements in rheumatology to deliver the best possible care.
Driven by the desire to join clinical and lab research, my academic background includes a Ph.D. and post-doctoral experience conducted in specialized centers abroad (Charité hospital Berlin and Gothenburg University in Sweden) where I focused on the study of B cell abnormalities in SLE, LN as well as other autoimmune conditions, gaining skills in laboratory research including flow-cytometry, cell culturing and stimulation and RNA extraction, and parallelly developing mentoring skills for younger fellows.
I recognize the importance of collaboration in the scientific community and am fortunate to maintain connections with colleagues around the world, which leads to a continuous enrichment in knowledge and to fruitful cooperations resulting in joint research projects and exchange of younger fellows/students between our academic centers.
In essence, my journey in patient care and research always brought me at the intersection of clinical practice and scientific exploration, constantly learning and humbly contributing to original advancements in the field of SLE and LN.
My ultimate goal is to make a positive impact on the lives of individuals dealing with lupus and connective tissue diseases, and to extend my fondness to younger fellows.
-
11:30-12:00 - Salão Nobre ICBAS
30 min
Coffee break
-
12:00-12:45 - Salão Nobre ICBAS
45 min
Highligts: summary and future agenda
SpeakerLuísa Viveiros
SpeakerAna Marçal
SpeakerJoão Guilherme Neves Maia
SpeakerMarta Cunha
Luísa Viveiros
Ana Marçal
João Guilherme Neves Maia
Marta Cunha
-
12:45-13:00 - Salão Nobre ICBAS
15 min
Closing Session
-
14:45-16:45 - Salão Nobre ICBAS
120 min
Autoimmune Disease Patient Meeting
SpeakerCarlos Vasconcelos
New Treatment Strategies: What They Mean in Clinical PracticeSpeakerAntónio Marinho
New Drugs in Autoimmune DiseasesSpeakerDaniel Guimarães De Oliveira
How Patients Can Influence Autoimmune Disease Consultations from the Physician’s PerspectiveCarlos Vasconcelos
António Marinho
Daniel Guimarães De Oliveira
Dr. Daniel Guimarães de Oliveira is an Internist dedicated to immune-mediated diseases. He works at the Autoimmune Diseases and Immunology Unit (UDAI) of ULS Tâmega e Sousa as well as in private practice. His clinical and research interests focus on systemic lupus erythematosus (SLE). He leads national and international projects on social determinants of health, quality of life, and the gut microbiome in lupus, and is actively engaged in patient involvement and co-design initiatives.
The PAM – Porto’s Autoimmune Meeting, Porto, Portugal 13/11/2025 – 15/11/2025PAM – Porto’s Autoimmune Meeting, Porto, Portugal 13/11/2025 – 15/11/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16.016.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
